MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 47 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 61.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,620,294 | +14.1% | 2,780,740 | +4.9% | 0.00% | – |
| Q2 2023 | $7,555,920 | -7.5% | 2,651,200 | +27.8% | 0.00% | – |
| Q1 2023 | $8,172,970 | +19.4% | 2,074,358 | +20.1% | 0.00% | – |
| Q4 2022 | $6,842,203 | – | 1,727,829 | +34556480.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 5 | -99.9% | 0.00% | – |
| Q2 2020 | $18,000 | -14.3% | 4,717 | -59.4% | 0.00% | – |
| Q1 2020 | $21,000 | – | 11,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |